Figure 2.miR-432-5p alleviates ADR-caused cardiomyocytes injury. (A) The relative level of miR-432-5p in primary cardiomyocytes treated with ADR; (B) The relative level of miR-432-5p in ADR-treated mice; (C) The miR-432-5p mimic was transfected to primary cardiomyocytes, RT-PCR was performed to confirm the successful of transfection; (D–G) The increasing of miR-432-5p improved the cell viability caused by ADR; decreased ROS, IL-1β, and LDH levels in ADR treated cells. *p < 0.05, **p < 0.01, ***p < 0.001.
